- Home
- NCTY vs ASRT Comparison
NCTY vs ASRT Comparison
Compare NCTY & ASRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NCTY | ASRT |
|---|---|---|
| Founded | 1999 | 1995 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Business Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 93.8M | 76.0M |
| IPO Year | 2004 | 2004 |
Fundamental Metrics
Financial Performance| Metric | NCTY | ASRT |
|---|---|---|
| Price | $5.44 | $19.15 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $35.00 |
| AVG Volume (30 Days) | 22.8K | ★ 103.8K |
| Earning Date | 03-27-2015 | 03-16-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $118,713,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $16.87 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $5.00 | $0.51 |
| 52 Week High | $15.98 | $20.45 |
Technical Indicators
Market Signals| Indicator | NCTY | ASRT |
|---|---|---|
| Relative Strength Index (RSI) | 43.98 | 84.05 |
| Support Level | $5.02 | $0.69 |
| Resistance Level | $7.22 | N/A |
| Average True Range (ATR) | 0.55 | 1.10 |
| MACD | -0.04 | 0.75 |
| Stochastic Oscillator | 15.93 | 85.41 |
Price Performance
Historical ComparisonAbout NCTY The9 Limited American Depository Shares
The9 Ltd operates a cryptocurrency mining business. It provides computing power, or hash rate, to a Bitcoin mining pool and is entitled to receive a fractional share of Bitcoin award from the Bitcoin mining pool in return. The company generates its revenues from customers in Greater China, Asia/Eastern Europe, and North America. Its segments are: Crypto mining business, and Other, out of which Crypto mining business derives maximum revenue.
About ASRT Assertio Holdings Inc.
Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older and Zipsor, liquid-filled capsules for relief of mild to moderate pain.